More precisely, in early clinical trials, Retatrutide has shown the potential for significant weight loss, with participants on the highest dose losing an average of 28.7% of their body weight over 68 weeks, which is double the weight loss seen with other GLP-1 medications like Ozempic and Wegovy
High amounts of caffeine can worsen these effects, potentially leading to palpitations, jitteriness, or anxiety
Food and Drug Administration (FDA) says that more than 0.4 percent of Ozempic users have reported dysgeusia as a side effect
Reconstituted solution: Refrigerate at 4 C (39 F)
After the colonization had stabilized, a d9-OCCT was performed with d9-carnitine via gavage to measure TMAO productivity in each hGM group
Someone starting at 250 pounds may lose 20 pounds